XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Corlieve transaction - Narrative (Details)
$ in Thousands, € in Millions
12 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2021
EUR (€)
Jul. 30, 2021
USD ($)
employee
Institution
Jul. 30, 2021
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
Dec. 31, 2022
EUR (€)
Jul. 30, 2021
EUR (€)
employee
Institution
Business Acquisition [Line Items]                    
Contingent consideration, net of current portion         $ 9,334   $ 29,542      
Enacted tax rate         25.80% 25.80% 25.00% 25.00%    
Goodwill         $ 25,581   $ 27,633      
Repayment of debt acquired through acquisition of Corlieve             1,572      
Acquisition of Corlieve                    
Business Acquisition [Line Items]                    
Number of institutions | Institution     2             2
Number of employees employed | employee     7             7
Net loss of Corlieve and its Swiss subsidiary             7,300      
Net loss from Corlieve and its Swiss subsidiary included in the consolidated results             4,100      
Percentage of outstanding ordinary shares     97.70%   100.00%       100.00% 97.70%
Value of shares issued     $ 53,300 € 44.9            
Contingent consideration, net of current portion     $ 24,000   $ 35,300   $ 29,500     € 20.2
Weighted average cost of capital     10.40%             10.40%
Provisional fair value of IPR&D intangible asset     $ 63,600             € 53.6
Deferred tax assets     1,700             1.5
Intangible assets     $ 15,900             13.4
Enacted tax rate     25.00% 25.00%            
Deferred tax liability, net     $ 14,200             11.9
Goodwill     28,400             23.9
Repayment of debt acquired through acquisition of Corlieve $ 1,200 € 1.0 400 € 0.4            
Current assets     3,400             2.9
Cash     3,300             2.8
Current liabilities     $ 1,300             € 1.1
Acquisition of remaining outstanding ordinary shares         1,900 € 1.8        
Acquisition of Corlieve | Maximum                    
Business Acquisition [Line Items]                    
Consideration payable in development milestones through phase I or II         42,800       € 40.0  
Consideration payable in development milestones through phase III         $ (171,300)       € 160.0  
Percentage of milestones payable through the issuance of shares         25.00% 25.00%